Central Data Catalog

Citation Information

Type Journal Article - Malar. J.
Title Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
Author(s)
Volume 12
Issue 1
Publication (Day/Month/Year) 2013
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=Results+from+tandem+Phase+1+studies+evaluating+the+safety,+​reactogenicity+and+immunogenicity+of+the+vaccine+candidate+antigen+Plasmodium+falciparum+FVO+merozoi​te+surface+protein-1+(MSP142)+administered+intramuscula
Otsyula, Nekoye, Evelina Angov, Elke Bergmann-Leitner, Margaret Koech, Farhat Khan, Jason Bennett, Lucas Otieno, James Cummings, Ben Andagalu, Donna Tosh, John Waitumbi, Nancy Richie, Meng Shi, Lori Miller, Walter Otieno, Godfrey Allan Otieno, Lisa Ware, Brent House, Olivier Godeaux, Marie-Claude Dubois, Bernhards Ogutu, W Ripley Ballou, Lorraine Soisson, Carter Diggs, Joe Cohen, Mark Polhemus, D Gray, Jr Heppner, Christian F Ockenhouse, and Michele D Spring. "Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01." Malar. J. 12, no. 1 (2013).